Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries.
VASSALL, A; SWEENEY, S; Barasa, E; Prinja, S; KEOGH-BROWN, MR; Tarp Jensen, H; Smith, R; Baltussen, R; M Eggo, R; JIT, M;
2022
Wellcome open research, (2022).5, 10.12688/wellcomeopenres.16380.2.
covid19-forecast-hub-europe/euro-hub-ensemble: Zenodo release.
Sherratt, K; FUNK, S;
2022
, Zenodo (2022).
Changes in STI and HIV testing and testing need among men who have sex with men during the UK's COVID-19 pandemic response.
Brown, JR; Reid, D; Howarth, AR; Mohammed, H; Saunders, J; Pulford, CV; HUGHES, G; Mercer, CH;
2022
Sexually Transmitted Infections, (2022).99 4 10.1136/sextrans-2022-055429.
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
Hulme, WJ; WILLIAMSON, EJ; Green, AC A; BHASKARAN, K; MCDONALD, HI; RENTSCH, CT; SCHULTZE, A; TAZARE, J; Curtis, HJ; Walker, AJ; TOMLINSON, LA; Palmer, T; Horne, EM F; MacKenna, B; Morton, CE; Mehrkar, A; Morley, J; Fisher, L; Bacon, SC J; Evans, D; Inglesby, P; Hickman, G; Davy, S; Ward, T; Croker, R; ... GOLDACRE, B.
2022
BMJ, (2022).378, 10.1136/bmj-2021-068946.
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records.
Horne, EM F; Hulme, WJ; KEOGH, RH; Palmer, TM; WILLIAMSON, EJ; PARKER, EP K; Green, A; Walker, V; Walker, AJ; Curtis, H; Fisher, L; MacKenna, B; Croker, R; Hopcroft, L; Park, RY; Massey, J; Morley, J; Mehrkar, A; Bacon, S; Evans, D; Inglesby, P; Morton, CE; Hickman, G; Davy, S; Ward, T; ... Sterne, JA C.
2022
British Medical Journal, (2022).378, 10.1136/bmj-2022-071249.
Experiences and practices of people categorised as being 'at risk' based on age during the COVID-19 pandemic: a qualitative study in the UK and Germany.
Wabnitz, K; Drössler, S; MAYHEW, S;
2022
BMJ Open, (2022).12 7 10.1136/bmjopen-2021-059499.
Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END).
McCaul, M; Tovey, D; Young, T; Welch, V; Dewidar, O; Goetghebeur, M; Kredo, T; Tricco, AC; GLOVER, RE; Tufte, J; Qaseem, A; Ludovic, R; Morgan, RL; Vandvik, PO; Florez, ID; COVID-END Recommending, Synthesizing and Equity Wo,;
2022
Journal of clinical epidemiology, (2022).151, 10.1016/j.jclinepi.2022.07.008.
Data for Figures and Tables in "Bounce backs amid continued losses: Life expectancy changes since COVID-19".
Schöley, J; ABURTO, JM; Kashnitsky, I; Kniffka, MS; Zhang, L; Jaadla, H; Dowd, JB; Kashyap, R;
2022
, Zenodo (2022).
Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning.
Nickbakhsh, S; Hughes, J; Christofidis, N; Griffiths, E; Shaaban, S; Enright, J; Smollett, K; Nomikou, K; Palmalux, N; Tong, L; Carmichael, S; Sreenu, VB; Orton, R; Goldstein, EJ; Tomb, RM; COVID-19 Genomics UK (COG-UK) Consortium,; Templeton, K; Gunson, RN; Da Silva Filipe, A; Milosevic, C; THOMSON, E; Robertson, DL; Holden, MT G; Illingworth, CJ R; Smith-Palmer, A;
2022
Scientific Reports, (2022).12 1 10.1038/s41598-022-15661-1.
Life table data for "Bounce backs amid continued losses: Life expectancy changes since COVID-19".
Schöley, J; ABURTO, JM; Kashnitsky, I; Kniffka, MS; Zhang, L; Jaadla, H; Dowd, JB; Kashyap, R;
2022
, Zenodo (2022).